A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION.

"R. G. Devenyi and S. N. Markowitz report clinical research agreements and fees from LumiThera Inc, for the conduct of the study. M. R. Munk received lecturer fees from Novartis (Novartis AG) and travel support from Bayer (Bayer AG) and is a consultant for Allergan and Zeiss and reports fees from LumiThera Inc, during the conduct of the study. M. G. Walker and R. Rückert report personal fees and other from LumiThera Inc, during the conduct of the study. LumiThera employees received grant support from National Institutes of Health, National Eye Institute #3R43EY025508 to 01S1. C. E. Tedford and S. E. Stephanie Tedford as well as C. L. Croissant are employees of LumiThera, Inc. The remaining authors have no financial/conflicting interests to disclose."

"The sponsor supported clinical site costs, data management, data analysis, and preparation of the manuscript. The study was partially supported by the National Institutes of Health, National Eye Institute #3R43EY025508-01S1."